Document ID: chunk:federal_register_of_legislation:F2022L00266:reg:8
Version: federal_register_of_legislation:F2022L00266
Segment Type: reg
Provision Reference: reg 8
Character Range: 3705–5510

8               Factors that must exist
At least one of the following factors must as a minimum exist before it can be said that a reasonable hypothesis has been raised connecting eosinophilic oesophagitis or death from eosinophilic oesophagitis with the circumstances of a person's relevant service:
(1)          taking an average of at least 600 milligrams of aspirin per day for the desensitisation of aspirin-exacerbated respiratory disease for at least the 3 months before the clinical onset of eosinophilic oesophagitis;
(2)          taking carbamazepine daily for at least the 7 days before the clinical onset of eosinophilic oesophagitis;
(3)          having oral or sublingual allergen immunotherapy at the time of the clinical onset of eosinophilic oesophagitis;
(4)          undergoing organ or tissue transplantation, excluding corneal transplant, before the clinical onset of eosinophilic oesophagitis;
Note: organ or tissue transplantation is defined in the Schedule 1 – Dictionary.
(5)          taking an average of at least 600 milligrams of aspirin per day for the desensitisation of aspirin-exacerbated respiratory disease for at least the 3 months before the clinical worsening of eosinophilic oesophagitis;
(6)          taking carbamazepine daily for at least the 7 days before the clinical worsening of eosinophilic oesophagitis;
(7)          having oral or sublingual allergen immunotherapy at the time of the clinical worsening of eosinophilic oesophagitis;
(8)          undergoing organ or tissue transplantation, excluding corneal transplant, before the clinical worsening of eosinophilic oesophagitis;
Note: organ or tissue transplantation is defined in the Schedule 1 – Dictionary.
(9)          inability to obtain appropriate clinical management for eosinophilic oesophagitis.